First published 10/3/2026, 10:48:15 PM · Last updated 10/3/2026, 10:48:15 PM

Prognostic Value of Early Weight Gain in Patients With Stage IV Gastric Cancer Undergoing First-Line Combination Immunotherapy

Journal article assessing whether early weight gain predicts outcomes in patients with Stage IV gastric cancer receiving first-line combination immunotherapy. Publisher metadata is provided but no study results, location, or patient numbers are included in the supplied source data.

Illustrative image: Albucasis (Al-Zahwari) blistering a patient in the hospital at Cordova, 1100 AD. Iconographic Collections Keywords: albucasis; i.c.; ic; Surgeon; Surgery; Spain; Ab¯ual-Q¯asim Khalaf ibn `Abb¯as al-Zahr¯aw¯i,; Ernest Board — w:Ernest Board/Wikimedia Commons, CC BY 4.0

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 3/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article examines a potential prognostic marker for advanced gastric cancer treated with combination immunotherapy.

Sources

Prognostic Value of Early Weight Gain in Patients With Stage IV Gastric Cancer Undergoing First-Line Combination ImmunotherapyMetadata provided by Crossref. Usage terms

Report an issue